aTYR PHARMA INC — Director's Dealing 2024

Jun 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (ATYR)
CIK: 0001339970
Period of Report: 2024-06-05

Reporting Person: DENYES NANCY (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-05	Common Stock	P	5000	$1.8552	Acquired	22267	Direct

Footnotes

F1: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.

F2: Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.